Skip to content

Plexus

US · PLXS #1741 by market cap Listed 1970
189.89 -18.84 -9.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:52

✦ Quant Financial Health how this is computed

Good
  • Altman Z-Score is 3.84, above the 3.0 "safe zone" threshold.
  • Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +23.11% YoY

Margins

Gross margin
10.12%
Operating margin
5.31%
Net margin
4.08%

Key ratios & quality

PEG uses trailing P/E against the 3-year net income growth rate (13.34%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item 2019 2020 2021 2022 2023 2024 2025 2026
Revenue 3.16B3.39B3.37B3.81B4.21B3.96B4.03B4.96B
Gross profit 291.84M312.71M323.30M347.23M394.55M378.53M406.51M502.67M
Selling & admin expenses 148.11M153.33M143.76M167.02M175.64M190.54M199.46M238.83M
Research & development ----------------
Operating profit 143.73M159.38M179.54M180.21M218.91M187.99M207.05M263.84M
Pretax profit 125.96M135.40M160.41M158.30M161.01M129.53M188.02M245.83M
Tax 17.34M17.92M21.50M20.06M21.92M17.72M15.13M43.34M
Net profit 108.62M117.48M138.91M138.24M139.09M111.82M172.89M202.49M
Basic EPS 44555468
Diluted EPS 3.503.934.764.864.954.016.267.41

Balance sheet

Line item 2019 2020 2021 2022 2023 2024 2025 2026
Total current assets 1.54B1.78B1.93B2.82B2.67B2.48B2.40B3.16B
Cash & ST investments 223.76M385.81M270.17M274.81M256.23M345.11M306.46M281.18M
Inventory 700.94M763.46M972.31M1.60B1.56B1.31B1.23B1.67B
Total assets 2.00B2.29B2.46B3.39B3.32B3.15B3.14B3.93B
Total current liabilities 865.50M1.00B1.13B2.01B1.81B1.64B1.52B2.21B
Short-term debt 100.70M146.83M66.31M273.97M240.21M157.33M45.79M179.52M
Long-term debt 187.28M187.98M187.03M187.78M190.85M89.99M91.99M81.24M
Total liabilities 1,135,307,000.001,312,368,000.001,433,661,000.002,297,494,000.002,106,790,000.001,828,996,000.001,682,522,000.002,360,829,000.00
Total equity 865.58M977.48M1.03B1.10B1.21B1.32B1.45B1.57B
Retained earnings 1.18B1.30B1.43B1.57B1.71B1.82B2.00B2.20B

Cash flow

Line item 2019 2020 2021 2022 2023 2024 2025 2026
Operating cash flow 115.30M210.37M142.58M-26.24M165.82M436.50M249.23M68.20M
Depreciation & amortization 52.21M56.69M61.01M62.69M69.76M77.85M77.79M77.03M
Free cash flow 24.70M160.28M85.48M-127.85M61.77M341.32M153.97M-28.94M
Dividends paid ----------------
Stock buybacks / issuance -182.11M-41.39M-108.45M-50.39M-40.95M-55.69M-65.34M-85.43M
Ending cash balance 226.25M387.89M270.51M275.47M256.65M347.46M306.76M281.22M

Returns & efficiency

Line item 2019 2020 2021 2022 2023 2024 2025 2026
ROE % 12.1612.7513.8513.0212.048.8112.4413.38
ROA % 5.525.485.854.724.143.455.505.73
ROIC % 10.4310.3811.2510.379.998.1111.1612.17
5-year avg ROE % 9.079.2910.3310.6212.7612.0912.03--
EBIT margin % 4.394.475.184.574.574.004.955.26
FCF / sales % 0.784.732.54--1.478.623.82--
Current ratio 1.781.771.711.401.471.511.581.43
Quick ratio 0.930.980.800.570.580.660.730.64
Debt / assets 14.3916.2311.8314.6014.148.875.337.21
LT debt / equity 21.6422.9921.8820.2118.899.238.356.63
Interest coverage 10.809.3812.2510.986.105.4917.2017.02
Revenue CAGR (3Y) % 7.3810.285.446.407.495.541.905.65
Net income CAGR (3Y) % 12.431.59120.038.375.79-6.987.7413.34
FCF CAGR (3Y) % -36.536.36176.33---27.2358.65----

Revenue breakdown most recent period

Business

Single segment100.00%

Quote time 2026-11-20 19:52:45 · For reference only, not investment advice and not tailored to your situation.

Plexus discussion 0 comments

Add a comment